News | February 18, 2023
IAGES collaborates with technology leaders in robotic surgery
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The company is one of the most profitable companies manufacturing speciality chemicals in India
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Subscribe To Our Newsletter & Stay Updated
